Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Crohn's Disease
Sort By
Newest First
1 / 1
1 / 1
Crohn's Disease
Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn's Disease
Theravance Biopharma
PR-M11-18-NI-092
Nov 27, 2018
Market Prediction
Global Crohn's Disease Therapeutics Market to 2025 with Johnson & Johnson Services Inc. Pfizer Inc. Allergan and AbbVie Dominating
ResearchandMarkets
PR-M11-18-NI-049
Nov 14, 2018
